Wound Healing News and Research RSS Feed - Wound Healing News and Research

WPI receives patent for novel method of reprogramming human skin cells

WPI receives patent for novel method of reprogramming human skin cells

Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration. [More]
Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Great discoveries do come in small packages. Few know that better than Ann-Marie Broome, Ph.D., who feels nanotechnology holds the future of medicine with its ability to deliver powerful drugs in tiny, designer packages. [More]
Two-way communication between cancer cells may be key to tumor metastasis

Two-way communication between cancer cells may be key to tumor metastasis

Two-way communication between cancer cells appears to be key to their becoming motile, clustering and spreading through metastasis, according to Rice University scientists. [More]
Major breakthrough in understanding impact of oxygen exposure on aging process

Major breakthrough in understanding impact of oxygen exposure on aging process

A study published in the US journal, Aging by the University of Surrey and University of Rochester has made an important breakthrough in understanding the impact of oxygen exposure on the aging process of mammal cells. [More]
Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress. [More]
Scientists find way to reduce need for secondary cataract surgery

Scientists find way to reduce need for secondary cataract surgery

Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract - the world's leading cause of blindness. [More]
Researchers discover gene that plays vital role in inherited eye disorder

Researchers discover gene that plays vital role in inherited eye disorder

Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder. [More]
Vegetable-based polyphenol enhances wound healing

Vegetable-based polyphenol enhances wound healing

A research group led by Osaka University found a plant-based polyphenol, promotes the migration of Mesenchymal Stem Cells (MSCs) in blood circulation and accumulates them in damaged tissues to improve wound healing. It is anticipated that the results will be used for stem cell treatments for cutaneous disorders associated with various damage and lesions. [More]
Magnesium could be safe, cost-effective therapeutic intervention for genetic coagulation disorder

Magnesium could be safe, cost-effective therapeutic intervention for genetic coagulation disorder

An international team of scientists was able to demonstrate in mouse and patient studies, how magnesium affects the production of blood platelets and that the TRPM7 channel function plays a key role in this process. Scientists of the Rudolf Virchow Center and the Hospital of the University of Würzburg were primarily involved in this study. Their results were published in the current journal "Nature Communications". [More]
European researchers aim to spare people with type 1 diabetes from lifelong insulin therapy

European researchers aim to spare people with type 1 diabetes from lifelong insulin therapy

More and more children in Europe and the USA are suffering from diabetes. A Group of European Researchers has now joined forces under the leadership of the Gothe University Frankfurt. They are searching for a new method in order to spare people with Diabetes type 1 from lifelong insulin therapy. [More]
Immunoproteasome inhibits repair function of alveolar macrophages

Immunoproteasome inhibits repair function of alveolar macrophages

Scientists of Helmholtz Zentrum München, a partner in the German Center for Lung Research, have observed that the immunoproteasome inhibits the repair function of alveolar macrophages. [More]
Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility -- this discovery will make possible development of new drugs for curing onco- and vessel diseases. [More]
Anticancer drug restores hearing in neurofibromatosis patients

Anticancer drug restores hearing in neurofibromatosis patients

In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing. [More]
PKM2 enzyme plays major role in early steps of wound healing

PKM2 enzyme plays major role in early steps of wound healing

An enzyme involved in glucose metabolism in cells plays a major role in the early steps of wound healing, a finding that could lead to new therapeutic approaches for wound care, according to researchers at Georgia State University. [More]
Sustainable surgical follow-up program may be cost-effective in ensuring acceptable outcomes

Sustainable surgical follow-up program may be cost-effective in ensuring acceptable outcomes

Each year, hundreds of orthopaedic surgeons travel to developing countries to treat and care for patients. Yet despite the successful completion of many surgical procedures on patients who may not otherwise have access to care, adequate follow-up--so critical to optimal outcomes--is not always available or guaranteed. [More]
Study reveals another clue to workings of trachoma

Study reveals another clue to workings of trachoma

Another clue to the workings of trachoma - the world's leading infectious cause of blindness - has been revealed in a new study published in BMC Infectious Diseases. Researchers identified markers of genetic regulation present in the early stages of infection that could predispose children to developing the condition in its long-term, severe form. [More]
Neutrophils promote cardiac repair

Neutrophils promote cardiac repair

Following an acute heart attack, immune cells called neutrophils coordinate an inflammatory response which can exacerbate the damage to the organ. Now researchers from Ludwig-Maximilians-Universitaet in Munich have shown that neutrophils also promote cardiac repair. [More]
Discovery could lead to new leukaemia therapies

Discovery could lead to new leukaemia therapies

Human blood cells have olfactory receptors that respond to Sandalore. This could provide a starting point for new leukaemia therapies, as researchers from Bochum report in in the journal "Cell Death Discovery". [More]
CellSonic treatments reduce problems of muscles recovering after exertion

CellSonic treatments reduce problems of muscles recovering after exertion

Since non-invasive shockwaves were used forty years ago to remove kidney stones and became standard procedure in all hospitals worldwide for having no side effects, they have been used in many other applications. [More]
Newcastle University scientists use seaweed extract to develop 'Stem-gell' bandage for wound healing

Newcastle University scientists use seaweed extract to develop 'Stem-gell' bandage for wound healing

Publishing in STEM CELLS Translational Medicine Professor Che Connon and Dr Stephen Swioklo describe the low-cost seaweed solution. [More]
Advertisement